Boyce Sarah
Insider CIK 1629383 · RNA President and CEO, Director · AKCA President, Director · BLI Director · OABI Director · CTNM Director · RNA Director · ISIS Chief Business Officer · LGND Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RNA Atrium Therapeutics, Inc. | F Tax w/h | 2026-09-18 | 2026-09-22 | 126,418 | $8.95 | $1.13M | 138,668 | SEC↗ |
| RNA Atrium Therapeutics, Inc. | F Tax w/h | 2026-09-18 | 2026-09-22 | 126,418 | $8.95 | $1.13M | 138,668 | SEC↗ |
| CTNM Contineum Therapeutics, In | A Award deriv | 2026-06-26 | 2026-06-26 | 19,000 | — | $0 | 19,000 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 400,000 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 300,000 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 200,000 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 165,000 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 425,000 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 300,000 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 386,015 | — | $0 | 0 | SEC↗ |
| RNA Atrium Therapeutics, Inc. | A Award deriv | 2026-02-27 | 2026-03-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer | 2026-02-27 | 2026-02-27 | 474,861 | — | $0 | 0 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2026-01-21 | 2026-01-23 | 7,993 | $72.45 | $579.1K | 269,007 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2026-01-21 | 2026-01-23 | 6,394 | $72.45 | $463.2K | 277,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2026-01-07 | 2026-01-09 | 8,576 | $72.23 | $619.4K | 283,394 | SEC↗ |
| RNA Avidity Biosciences, Inc. | G Gift | 2025-12-18 | 2025-12-19 | 29,159 | — | $0 | 291,970 | SEC↗ |
| RNA Avidity Biosciences, Inc. | F Tax w/h | 2025-12-17 | 2025-12-19 | 15,742 | $71.87 | $1.13M | 321,129 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award | 2025-12-17 | 2025-12-19 | 31,000 | — | $0 | 336,871 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2025-09-05 | 2025-09-05 | 50,000 | — | $0 | 1,022,015 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2025-09-05 | 2025-09-05 | 50,000 | $1.24 | $62.0K | 355,871 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-09-05 | 2025-09-05 | 50,000 | $49.95 | $2.50M | 305,871 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2025-08-28 | 2025-08-29 | 25,000 | — | $0 | 1,072,015 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-08-28 | 2025-08-29 | 25,000 | $49.39 | $1.23M | 305,871 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2025-08-28 | 2025-08-29 | 25,000 | $1.24 | $31.0K | 330,871 | SEC↗ |
| CTNM Contineum Therapeutics, In | A Award deriv | 2025-06-26 | 2025-06-26 | 14,750 | — | $0 | 14,750 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-03-20 | 2025-03-21 | 31,540 | $31.06 | $979.6K | 305,871 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-01-21 | 2025-01-23 | 4,738 | $28.59 | $135.5K | 343,070 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-01-21 | 2025-01-23 | 5,659 | $28.59 | $161.8K | 337,411 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2025-01-06 | 2025-01-08 | 165,000 | — | $0 | 165,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award | 2025-01-06 | 2025-01-08 | 82,500 | — | $0 | 347,808 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2024-12-18 | 2024-12-19 | 31,855 | $32.66 | $1.04M | 265,308 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2024-09-23 | 2024-09-23 | 32,880 | $44.00 | $1.45M | 234,663 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award | 2024-09-19 | 2024-09-23 | 62,500 | — | $0 | 267,543 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award | 2024-09-19 | 2024-09-23 | 62,500 | — | $0 | 297,163 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2024-08-06 | 2024-08-07 | 28,000 | — | $0 | 461,015 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2024-08-06 | 2024-08-07 | 28,000 | $43.35 | $1.21M | 205,043 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2024-08-06 | 2024-08-07 | 28,000 | $1.24 | $34.7K | 233,043 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2024-07-09 | 2024-07-11 | 28,000 | — | $0 | 489,015 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2024-07-09 | 2024-07-11 | 28,000 | $1.24 | $34.7K | 233,043 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2024-07-09 | 2024-07-11 | 28,000 | $39.93 | $1.12M | 205,043 | SEC↗ |
| CTNM Contineum Therapeutics, In | A Award deriv | 2024-06-24 | 2024-06-24 | 29,500 | — | $0 | 29,500 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2024-06-18 | 2024-06-21 | 20,000 | — | $0 | 0 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2024-06-18 | 2024-06-21 | 20,000 | — | $0 | 20,000 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2024-06-18 | 2024-06-21 | 40,000 | — | $0 | 40,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2024-06-18 | 2024-06-20 | 32,074 | $39.13 | $1.26M | 142,543 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2024-06-18 | 2024-06-21 | 20,000 | — | $0 | 68,381 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award | 2024-06-17 | 2024-06-20 | 62,500 | — | $0 | 174,617 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award | 2024-06-17 | 2024-06-20 | 62,500 | — | $0 | 205,043 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2024-06-14 | 2024-06-14 | 35,767 | — | $0 | 517,015 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2024-06-14 | 2024-06-14 | 35,767 | $40.08 | $1.43M | 112,117 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2024-06-14 | 2024-06-14 | 35,767 | $1.24 | $44.4K | 147,884 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2024-06-13 | 2024-06-14 | 164,233 | — | $0 | 552,782 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2024-06-13 | 2024-06-14 | 164,233 | $1.24 | $203.6K | 276,350 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2024-06-13 | 2024-06-14 | 164,233 | $40.08 | $6.58M | 112,117 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2024-06-12 | 2024-06-14 | 100,000 | — | $0 | 717,015 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2024-06-12 | 2024-06-14 | 100,000 | $35.73 | $3.57M | 112,117 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2024-06-12 | 2024-06-14 | 100,000 | $1.24 | $124.0K | 212,117 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2024-06-04 | 2024-06-05 | 28,000 | — | $0 | 817,015 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2024-06-04 | 2024-06-05 | 28,000 | $1.24 | $34.7K | 140,117 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2024-06-04 | 2024-06-05 | 28,000 | $27.42 | $767.8K | 112,117 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2024-05-07 | 2024-05-07 | 28,000 | — | $0 | 845,015 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2024-05-07 | 2024-05-07 | 28,000 | $25.54 | $715.1K | 112,117 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2024-05-07 | 2024-05-07 | 28,000 | $1.24 | $34.7K | 140,117 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2024-04-02 | 2024-04-03 | 28,000 | — | $0 | 873,015 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2024-04-02 | 2024-04-03 | 28,000 | $26.25 | $735.0K | 112,117 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2024-04-02 | 2024-04-03 | 28,000 | $1.24 | $34.7K | 140,117 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2024-03-12 | 2024-03-12 | 28,000 | — | $0 | 901,015 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2024-03-12 | 2024-03-12 | 28,000 | $1.24 | $34.7K | 140,117 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2024-03-12 | 2024-03-12 | 28,000 | $22.63 | $633.6K | 112,117 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2024-03-08 | 2024-03-12 | 84,000 | — | $0 | 929,015 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2024-03-08 | 2024-03-12 | 84,000 | $1.24 | $104.2K | 196,117 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2024-03-08 | 2024-03-12 | 84,000 | $21.39 | $1.80M | 112,117 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2024-03-01 | 2024-03-05 | 84,000 | — | $0 | 1,013,015 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2024-03-01 | 2024-03-05 | 84,000 | $20.13 | $1.69M | 112,117 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2024-03-01 | 2024-03-05 | 84,000 | $1.24 | $104.2K | 196,117 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2024-01-22 | 2024-01-23 | 5,092 | $10.13 | $51.6K | 44,008 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2024-01-20 | 2024-01-23 | 300,000 | — | $0 | 300,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award | 2024-01-20 | 2024-01-23 | 62,500 | — | $0 | 67,209 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2023-09-11 | 2023-09-12 | 200,000 | — | $0 | 200,000 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2023-06-23 | 2023-06-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2023-06-23 | 2023-06-27 | 40,000 | — | $0 | 40,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2023-02-03 | 2023-02-03 | 3,221 | — | $0 | 1,097,015 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2023-02-03 | 2023-02-03 | 3,221 | $24.26 | $78.1K | 53,352 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2023-02-03 | 2023-02-03 | 3,221 | $1.24 | $4.0K | 56,573 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2023-02-02 | 2023-02-03 | 45,879 | — | $0 | 1,100,236 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2023-02-02 | 2023-02-03 | 45,879 | $1.24 | $56.9K | 99,231 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2023-02-02 | 2023-02-03 | 45,879 | $24.36 | $1.12M | 53,352 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2023-02-01 | 2023-02-03 | 900 | — | $0 | 1,146,115 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2023-02-01 | 2023-02-03 | 900 | $1.24 | $1.1K | 54,252 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2023-02-01 | 2023-02-03 | 900 | $24.27 | $21.8K | 53,352 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2023-01-30 | 2023-02-01 | 37,840 | — | $0 | 37,840 | SEC↗ |
| OABI OmniAb, Inc. | A Award | 2023-01-30 | 2023-02-01 | 8,753 | — | $0 | 46,190 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2023-01-20 | 2023-01-24 | 400,000 | — | $0 | 400,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award | 2023-01-20 | 2023-01-24 | 50,000 | — | $0 | 53,352 | SEC↗ |
| OABI OmniAb, Inc. | P Buy | 2022-11-10 | 2022-11-14 | 15,000 | $2.92 | $43.8K | 36,000 | SEC↗ |
| OABI OmniAb, Inc. | P Buy | 2022-11-09 | 2022-11-14 | 21,000 | $2.74 | $57.5K | 21,000 | SEC↗ |
| OABI OmniAb, Inc. | A Award | 2022-11-01 | 2024-04-23 | 39,628 | — | $0 | 48,381 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | D To issuer deriv | 2022-11-01 | 2022-11-03 | 4,340 | — | $0 | 0 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 37,840 | — | $0 | 37,840 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 13,994 | — | $0 | 13,994 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 10,565 | — | $0 | 10,565 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 22,616 | — | $0 | 22,616 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | D To issuer | 2022-11-01 | 2022-11-03 | 1,004 | — | $0 | 2,892 | SEC↗ |
| OABI OmniAb, Inc. | A Award | 2022-11-01 | 2022-11-03 | 37,437 | — | $0 | 37,437 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2022-08-25 | 2022-08-26 | 14,855 | — | $0 | 1,147,015 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2022-08-25 | 2022-08-26 | 14,855 | $23.07 | $342.7K | 0 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2022-08-25 | 2022-08-26 | 14,855 | $1.24 | $18.4K | 14,855 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2022-08-24 | 2022-08-26 | 35,045 | — | $0 | 1,161,870 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2022-08-24 | 2022-08-26 | 35,045 | $1.24 | $43.5K | 35,045 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2022-08-24 | 2022-08-26 | 35,045 | $22.80 | $799.0K | 0 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2022-08-15 | 2022-08-17 | 100 | — | $0 | 1,196,915 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2022-08-15 | 2022-08-17 | 100 | $1.24 | $124 | 100 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2022-08-15 | 2022-08-17 | 100 | $22.47 | $2.2K | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2022-06-10 | 2022-06-13 | 4,340 | — | $0 | 4,340 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2022-06-10 | 2022-06-13 | 1,004 | — | $0 | 3,896 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2022-01-21 | 2022-03-15 | 425,000 | — | $0 | 425,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2021-06-04 | 2021-06-07 | 3,269 | — | $0 | 3,269 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2021-06-04 | 2021-06-07 | 630 | — | $0 | 2,892 | SEC↗ |
| BLI Berkeley Lights, Inc. | A Award deriv | 2021-05-14 | 2021-05-18 | 4,900 | — | $0 | 4,900 | SEC↗ |
| BLI Berkeley Lights, Inc. | A Award | 2021-05-14 | 2021-05-18 | 1,400 | — | $0 | 1,400 | SEC↗ |
| BLI Berkeley Lights, Inc. | M Exercise deriv | 2021-03-01 | 2021-03-03 | 10,000 | — | $0 | 90,000 | SEC↗ |
| BLI Berkeley Lights, Inc. | S Sale | 2021-03-01 | 2021-03-03 | 3,773 | $60.08 | $226.7K | 6,227 | SEC↗ |
| BLI Berkeley Lights, Inc. | M Exercise | 2021-03-01 | 2021-03-03 | 10,000 | $8.90 | $89.0K | 10,000 | SEC↗ |
| BLI Berkeley Lights, Inc. | S Sale | 2021-03-01 | 2021-03-03 | 3,000 | $61.13 | $183.4K | 3,227 | SEC↗ |
| BLI Berkeley Lights, Inc. | S Sale | 2021-03-01 | 2021-03-03 | 3,227 | $62.37 | $201.3K | 0 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2021-02-02 | 2021-02-04 | 300,000 | — | $0 | 300,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2020-06-10 | 2020-06-12 | 2,468 | — | $0 | 2,468 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2020-06-10 | 2020-06-12 | 831 | — | $0 | 2,262 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2019-10-15 | 2019-10-16 | 5,283 | — | $0 | 5,283 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2019-10-15 | 2019-10-16 | 1,431 | — | $0 | 1,431 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | S Sale | 2019-07-15 | 2019-07-17 | 1,819 | $23.52 | $42.8K | 19,888 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | A Award | 2019-07-01 | 2019-07-03 | 813 | $20.04 | $16.3K | 21,707 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | A Award deriv | 2019-01-02 | 2019-01-04 | 173,000 | — | $0 | 173,000 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | A Award deriv | 2018-04-17 | 2018-04-18 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | A Award | 2018-04-17 | 2018-04-18 | 20,894 | — | $0 | 20,894 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | S Sale | 2018-01-16 | 2018-01-17 | 2,196 | $51.76 | $113.7K | 8,931 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise deriv | 2018-01-15 | 2018-01-17 | 5,367 | — | $0 | 10,427 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | A Award deriv | 2018-01-15 | 2018-01-17 | 12,916 | — | $0 | 12,916 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise | 2018-01-15 | 2018-01-17 | 5,367 | — | $0 | 11,127 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | A Award deriv | 2018-01-02 | 2018-01-02 | 58,125 | — | $0 | 58,125 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | J Other | 2018-01-01 | 2018-01-02 | 491 | $42.76 | $21.0K | 5,760 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | J Other | 2017-07-01 | 2017-07-03 | 17 | $40.66 | $691 | 5,269 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | S Sale | 2017-01-17 | 2017-01-18 | 506 | $46.29 | $23.4K | 5,252 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | S Sale | 2017-01-17 | 2017-01-18 | 855 | $46.29 | $39.6K | 4,463 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise deriv | 2017-01-15 | 2017-01-18 | 1,295 | — | $0 | 3,883 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | A Award deriv | 2017-01-15 | 2017-01-18 | 7,537 | — | $0 | 7,537 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise deriv | 2017-01-15 | 2017-01-18 | 2,188 | — | $0 | 4,374 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise | 2017-01-15 | 2017-01-18 | 2,188 | — | $0 | 5,318 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise | 2017-01-15 | 2017-01-18 | 1,295 | — | $0 | 5,758 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | A Award deriv | 2017-01-03 | 2017-01-04 | 45,225 | — | $0 | 45,225 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | J Other | 2017-01-01 | 2017-01-04 | 992 | $20.76 | $20.6K | 3,130 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | J Other | 2016-07-01 | 2016-07-01 | 403 | $20.76 | $8.4K | 2,138 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | S Sale | 2016-01-19 | 2016-01-19 | 872 | $41.46 | $36.2K | 1,735 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise deriv | 2016-01-15 | 2016-01-19 | 2,188 | — | $0 | 6,562 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | A Award deriv | 2016-01-15 | 2016-01-19 | 5,178 | — | $0 | 5,178 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise | 2016-01-15 | 2016-01-19 | 2,188 | — | $0 | 2,607 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | A Award deriv | 2016-01-04 | 2016-01-04 | 31,070 | — | $0 | 31,070 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | J Other | 2016-01-01 | 2016-01-04 | 419 | $47.71 | $20.0K | 419 | SEC↗ |
| ISIS ISIS PHARMACEUTICALS INC | A Award deriv | 2015-01-15 | 2015-01-20 | 8,750 | — | $0 | 8,750 | SEC↗ |
| ISIS ISIS PHARMACEUTICALS INC | A Award deriv | 2015-01-01 | 2015-01-05 | 52,500 | — | $0 | 52,500 | SEC↗ |